Congress Consensus Weekly - October 24, 2026
E2's October 23 research freeze identifies eight holdings, three new selections and three model exits. Explore the rankings, scores, 12.5% target weights and documented source limitations.
Three in. Three out. Same research rules.
Saturday, October 24 · Model signal freeze: Friday, October 23, 2026 · Approximately 3-minute read
This week’s Congress Consensus research snapshot shows a three-stock rotation in an eight-position hypothetical model portfolio. Five positions carry over from last week. The process is unchanged: we follow when trades become public, not when politicians originally traded.
What changed this week?
More movement, same discipline
Disclosure date matters
Not every disclosed asset is an E2 stock signal
How the E2 research process works
1. Look for genuine agreement. A qualifying company needs purchases disclosed by at least two distinct U.S. lawmakers within the 60-day observation window.
2. Rank consistently. The same five dimensions are applied: lawmaker consensus, disclosed purchase amounts, recency, contradictory sales and historical lawmaker quality. The weighting formula did not change this week.
3. Keep portfolios hypothetical. E2 allocates up to eight slots of 12.5% each. This week all eight slots are occupied, meaning a 0% target cash allocation before any real-world costs.
What the Premium research contains
Premium provides the complete eight-stock ranking, each E2 score, model NEW / HOLD / EXIT decisions and target weights. The public edition intentionally does not disclose the selected tickers.
Research note
No independently verified October 23 model performance figure is published in this edition. This is a point-in-time research snapshot; previously published performance through October 16 should not be interpreted as a return for this week.
Independent research using public congressional disclosure data and accessible secondary indexes. Individual filings can be late, incomplete, corrected or amended. Model decisions are hypothetical, are not executed securities trades and do not constitute personalized investment advice. Historical and hypothetical results cannot guarantee future performance.